TWI896607B - 填充於樹脂製容器之含銀鹽眼科用水性組合物 - Google Patents

填充於樹脂製容器之含銀鹽眼科用水性組合物

Info

Publication number
TWI896607B
TWI896607B TW110107071A TW110107071A TWI896607B TW I896607 B TWI896607 B TW I896607B TW 110107071 A TW110107071 A TW 110107071A TW 110107071 A TW110107071 A TW 110107071A TW I896607 B TWI896607 B TW I896607B
Authority
TW
Taiwan
Prior art keywords
aqueous composition
ophthalmic aqueous
eye drop
ophthalmic
dose
Prior art date
Application number
TW110107071A
Other languages
English (en)
Chinese (zh)
Other versions
TW202203920A (zh
Inventor
桃川雄介
飯田真希
浅田博之
藤澤豊実
Original Assignee
日商參天製藥股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商參天製藥股份有限公司 filed Critical 日商參天製藥股份有限公司
Publication of TW202203920A publication Critical patent/TW202203920A/zh
Application granted granted Critical
Publication of TWI896607B publication Critical patent/TWI896607B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Bridges Or Land Bridges (AREA)
TW110107071A 2020-03-31 2021-02-26 填充於樹脂製容器之含銀鹽眼科用水性組合物 TWI896607B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020-062252 2020-03-31
JP2020062252 2020-03-31

Publications (2)

Publication Number Publication Date
TW202203920A TW202203920A (zh) 2022-02-01
TWI896607B true TWI896607B (zh) 2025-09-11

Family

ID=77930318

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110107071A TWI896607B (zh) 2020-03-31 2021-02-26 填充於樹脂製容器之含銀鹽眼科用水性組合物

Country Status (8)

Country Link
US (1) US20230145529A1 (enExample)
EP (1) EP4129341A4 (enExample)
JP (4) JP7053966B2 (enExample)
KR (2) KR102705675B1 (enExample)
CN (1) CN115348871B (enExample)
CA (1) CA3176584A1 (enExample)
TW (1) TWI896607B (enExample)
WO (1) WO2021199814A1 (enExample)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005162648A (ja) * 2003-12-01 2005-06-23 Rohto Pharmaceut Co Ltd 防腐剤及びこれを含有する水性組成物
JP2005330276A (ja) * 2004-04-23 2005-12-02 Rohto Pharmaceut Co Ltd 防腐剤及びこれを含有する水性組成物
WO2020004247A1 (ja) * 2018-06-28 2020-01-02 株式会社Ｃｓｐアドバンスソリューションズ 流行性角結膜炎の治療用点眼剤、当該点眼剤を生成するプラズマ活性点眼剤生成装置、及び流行性角結膜炎の治療方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
KR100557679B1 (ko) * 2004-01-07 2006-03-07 뉴바이오 (주) 4차암모늄의 공중합에 의한 콘택트렌즈제조방법
JP2006162648A (ja) 2004-12-02 2006-06-22 Konica Minolta Business Technologies Inc 現像装置及び画像形成装置
BRPI0818459A2 (pt) * 2007-10-16 2015-04-14 Sun Pharma Advanced Res Co Ltd Composição farmacêutica adequada para uso oftálmico.
IN2014MN01555A (enExample) * 2012-02-27 2015-07-03 Rohto Pharma
KR20150119303A (ko) * 2013-02-15 2015-10-23 센주 세이야꾸 가부시키가이샤 항균성 금속을 함유하는 디플루프레드네이트 유액 조성물
US20160022648A1 (en) * 2013-03-13 2016-01-28 Santen Pharmaceutical Co., Ltd. Therapeutic agent for meibomian gland dysfunction
SG11201705138QA (en) * 2014-12-25 2017-07-28 Santen Pharmaceutical Co Ltd Aqueous ophthalmic solution
JP6611444B2 (ja) * 2015-03-24 2019-11-27 ロート製薬株式会社 眼科用組成物
TWI711453B (zh) 2015-06-05 2020-12-01 日商參天製藥股份有限公司 抑制水性點眼液中之洛赫西定類的殘存率降低之方法
JP6615548B2 (ja) * 2015-08-06 2019-12-04 ロート製薬株式会社 眼科組成物
JP7317714B2 (ja) * 2017-12-01 2023-07-31 参天製薬株式会社 眼科用製品
JP7139206B2 (ja) 2018-09-21 2022-09-20 小林製薬株式会社 医薬組成物

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005162648A (ja) * 2003-12-01 2005-06-23 Rohto Pharmaceut Co Ltd 防腐剤及びこれを含有する水性組成物
JP2005330276A (ja) * 2004-04-23 2005-12-02 Rohto Pharmaceut Co Ltd 防腐剤及びこれを含有する水性組成物
WO2020004247A1 (ja) * 2018-06-28 2020-01-02 株式会社Ｃｓｐアドバンスソリューションズ 流行性角結膜炎の治療用点眼剤、当該点眼剤を生成するプラズマ活性点眼剤生成装置、及び流行性角結膜炎の治療方法

Also Published As

Publication number Publication date
CN115348871A (zh) 2022-11-15
CA3176584A1 (en) 2021-10-07
JP2025146955A (ja) 2025-10-03
US20230145529A1 (en) 2023-05-11
KR20220161379A (ko) 2022-12-06
WO2021199814A1 (ja) 2021-10-07
JP7169477B2 (ja) 2022-11-10
JP2023001184A (ja) 2023-01-04
JPWO2021199814A1 (enExample) 2021-10-07
JP2022087168A (ja) 2022-06-09
EP4129341A4 (en) 2024-04-24
JP7053966B2 (ja) 2022-04-12
JP7721498B2 (ja) 2025-08-12
KR102705675B1 (ko) 2024-09-11
EP4129341A1 (en) 2023-02-08
CN115348871B (zh) 2025-08-08
KR20240135080A (ko) 2024-09-10
TW202203920A (zh) 2022-02-01

Similar Documents

Publication Publication Date Title
CN1376054A (zh) 含环丙沙星和地塞米松的局部悬浮制剂
JP6903448B2 (ja) ドルゾラミドとブリモニジンを含む医薬組成物
KR102075173B1 (ko) 보존 효력을 갖는 브롬페낙 수성 액제 조성물
TWI896607B (zh) 填充於樹脂製容器之含銀鹽眼科用水性組合物
JP2010265261A (ja) レボカバスチン懸濁型点眼剤
JP6267394B1 (ja) 水溶性粘稠化剤を含有する医薬組成物
JP6226997B2 (ja) 亜鉛を含有するジフルプレドナートエマルション組成物
JP6702754B2 (ja) ドルゾラミドを含有する防腐剤
US11324829B2 (en) Antiseptic agent comprising meglumine or salt thereof
JP6877613B2 (ja) 防腐効果のある医薬の組合せ
JP2019006756A (ja) 水溶性粘稠化剤を含有する医薬組成物
WO2023204297A1 (ja) セペタプロストを含有する眼科用組成物
JP2022180452A (ja) レバミピドまたはその塩および高分子を含有する水性懸濁液
JP2015044751A (ja) ラタノプロストとチモロールマレイン酸塩を配合した点眼液